Elies Molins Grau

Title: Elies Molins Grau: Innovator in Antifungal Compounds

Introduction

Elies Molins Grau is a notable inventor based in Bellaterra, Spain. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of antifungal compounds. With a total of two patents to his name, his work has the potential to impact the treatment of various microbial and fungal infections.

Latest Patents

Elies Molins Grau's latest patents focus on crystalline antifungal compounds. These patents describe novel crystalline forms of (1R,2R)-7-chloro-3-[2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]quinazolin-4(3H)-one. The patents detail pharmaceutical compositions containing these crystalline forms, methods for using them to treat and prevent various microbial and fungal infections, and processes for obtaining these crystalline forms. Specifically, the patents relate to crystalline Forms I, II, III, IV, V, and VI of the compound mentioned.

Career Highlights

Throughout his career, Elies has worked with reputable companies in the pharmaceutical industry. Notable among these are Palau Pharma and Stiefel Laboratories, Inc. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Elies has collaborated with several professionals in his field, including Antonio Cánovas Paredes and Javier Bartroli Orpi. These collaborations have likely enriched his research and development efforts.

Conclusion

Elies Molins Grau is a distinguished inventor whose work in antifungal compounds showcases his commitment to advancing pharmaceutical science. His patents reflect a significant contribution to the treatment of infections, highlighting the importance of innovation in healthcare.